IGC is one of China’s earliest in-depth conventions focused on the innovation and translation of cutting-edge therapies. Over the past eight years, as the fields of immunotherapy, cell therapy, and gene therapy have grown in China, IGC was founded in Wuhan and has since flourished in Beijing. The event has attracted over 14,000 professionals from industry, academia, research, and healthcare, and has invited more than 590 renowned experts, scholars, and leading scientists from top companies to speak, driving the industry applications of immunotherapy, cell therapy, and gene therapy.

From September 6-7, 2024, the 8th Immunotherapy, Gene Therapy and Cell Therapy Convention were grandly held at the Beijing International Conference Center. This year’s IGC features 12 specialized sessions and 2 technical satellite forums, including the International Regulatory and Technology Outlook Forum, CGT Commercialization and BD Investment & Financing Session, and specialized sessions on ImmunoCell/MSC/iPSC/Gene Editing/Exosomes/Organoids, among others. The event brought together experts and speakers, including researchers, KOLs, and industry leaders from the IO/GCT fields. Over the course of two days, the convention was expected to attract 5000 industry professionals.